SONNET BIOTHERAPEUTICS HOLDI (SONN)

US83548R3030 - Common Stock

1.79  +0.02 (+1.13%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-12-31)
2023
(2023-9-30)
2022
(2022-9-30)
2021
(2021-9-30)
2020
(2019-12-31)
Revenue
135.89K147.81K350.00K480.00K30.14M
Minority Interest Expense
N/AN/AN/AN/A400.00K
Cost Of Goods
N/AN/AN/AN/A28.24M
Gross Profit
N/AN/AN/AN/A1.90M
Operating Expenses
14.58M18.94M30.02M25.57M8.83M
Research and Development
8.72M11.81M21.44M16.63M9.88M
Selling, General, and Administrative Expenses
5.87M7.13M8.58M8.94M6.98M
Operating Income
-14.46M-18.79M-29.67M-25.09M-6.93M
Interest Income/Expense
3.77K-40.08K-50.00K-20.00K-670.00K
Other Income/Expense
N/AN/A0.00130.00K-620.00K
Non Recurring Items
N/AN/AN/A0.00-9.15M
Income Before Taxes
-14.47M-18.83M-29.72M-24.98M-17.37M
Income Tax
N/AN/AN/AN/A70.00K
Net Income
-14.47M-18.83M-29.72M-24.98M-17.84M
EBITDA
N/A-18.78M-29.66M-25.08M-5.09M
 
Per Share Data
EPS Diluted Total Ops
-12.91-18.14-148.60-312.25-19.68K
Non GAAP EPS
-12.74-30.03-150.70N/AN/A
 
Statistics
Gross Profit Margin
N/AN/AN/AN/A6.30%
Profit Margin
-10644.82%-12741.15%-8491.43%-5204.17%-59.19%
Operating Profit Margin
-10640.23%-12714.03%-8477.14%-5227.08%-22.99%

All data in USD

Charts